BAUSCH HEALTH AMERICAS, INC.
🇺🇸United States
Dose Ranging Study in Healthy Methadone Maintenance Subjects
Phase 1
Completed
- Conditions
- Adult
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT00387491
Bioequivalence Study in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- Bausch Health Americas, Inc.
- Registration Number
- NCT00387985
Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
Phase 3
Completed
- Conditions
- Post Operative Bowel Dysfunction
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 495
- Registration Number
- NCT00387309
Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain
Phase 2
Completed
- Conditions
- Constipation
- First Posted Date
- 2006-08-21
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 420
- Registration Number
- NCT00366431
Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)
Completed
- Conditions
- Facial Lipoatrophy
- First Posted Date
- 2006-08-07
- Last Posted Date
- 2019-09-18
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 290
- Registration Number
- NCT00360932
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
A Study Comparing the Effectiveness and Safety of Extended-release Tramadol Versus Placebo in the Treatment of Chronic Low Back Pain
Phase 3
Completed
- Conditions
- Chronic Pain
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2012-06-21
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT00347724
A Study Comparing the Effectiveness and Safety of Extended Release Tramadol Versus Placebo for the Treatment of Osteoarthritis (OA) of the Knee
Phase 3
Completed
- Conditions
- Chronic Pain
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2012-06-21
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 245
- Registration Number
- NCT00348010
A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.
Phase 3
Completed
- Conditions
- Chronic Pain
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2012-06-21
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 650
- Registration Number
- NCT00347685
- Locations
- 🇺🇸
Gainesville Clinical Research Center, Gainesville, Florida, United States
A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA)
Phase 3
Completed
- Conditions
- Chronic Pain
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2012-06-21
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 1000
- Registration Number
- NCT00348452
Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.
Phase 3
Completed
- Conditions
- Diarrhea
- First Posted Date
- 2006-05-19
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 660
- Registration Number
- NCT00328380
- Locations
- 🇺🇸
Southwest Doctors, PA, Houston, Texas, United States
🇺🇸Sunshine Medical Center, South Miami, Florida, United States
🇺🇸La Porte Family Clinic, La Porte, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath